Allogeneic processed thymus tissue Drug Interactions
Currently displaying a list of 253 drugs known to interact with allogeneic processed thymus tissue.
- 253 major drug interactions
Medications known to interact with allogeneic processed thymus tissue
Note: Showing generic names only.
- abatacept
- abemaciclib
- abrocitinib
- acalabrutinib
- adalimumab
- adenovirus vaccine
- afamitresgene autoleucel
- alefacept
- alemtuzumab
- anakinra
- anifrolumab
- anthrax vaccine adsorbed
- anti-thymocyte globulin (rabbit)
- apremilast
- asciminib
- auranofin
- avacopan
- axicabtagene ciloleucel
- azathioprine
- baricitinib
- basiliximab
- bcg
- bcg vaccine
- belatacept
- belimumab
- belinostat
- belumosudil
- benralizumab
- betamethasone
- bimekizumab
- blinatumomab
- brentuximab
- brexucabtagene autoleucel
- brodalumab
- budesonide
- canakinumab
- carfilzomib
- certolizumab
- chikungunya vaccine, live (cvx 317)
- chikungunya vaccine, recombinant (cvx 329)
- cholera vaccine
- cholera vaccine, live
- ciltacabtagene autoleucel
- cladribine
- cortisone
- COVID-19 mRNA (Moderna) vaccine
- COVID-19 mRNA (Pfizer) vaccine
- crovalimab
- cyclophosphamide
- cyclosporine
- daclizumab
- danicopan
- daratumumab
- dasatinib
- deflazacort
- dengue vaccine
- denosumab
- deucravacitinib
- dexamethasone
- dimethyl fumarate
- dinutuximab
- diroximel fumarate
- dupilumab
- duvelisib
- eculizumab
- efalizumab
- efgartigimod alfa
- eflornithine
- elotuzumab
- elranatamab
- emapalumab
- epcoritamab
- etanercept
- etrasimod
- everolimus
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- human papillomavirus vaccine
- hydrocortisone
- hydroxychloroquine
- ibritumomab
- ibrutinib
- idecabtagene vicleucel
- idelalisib
- imetelstat
- inavolisib
- inebilizumab
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- iptacopan
- isatuximab
- ixekizumab
- leflunomide
- lenalidomide
- lifileucel
- lisocabtagene maraleucel
- loncastuximab tesirine
- lurbinectedin
- lymphocyte immune globulin, anti-thy (equine)
- measles virus vaccine
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- mepolizumab
- mercaptopurine
- methotrexate
- methylprednisolone
- mirikizumab
- mixed respiratory vaccine
- mogamulizumab
- momelotinib
- monomethyl fumarate
- mosunetuzumab
- mumps virus vaccine
- muromonab-cd3
- mycophenolate mofetil
- mycophenolic acid
- pacritinib
- palbociclib
- panobinostat
- pazopanib
- pegcetacoplan
- pertussis, acellular
- pirtobrutinib
- plague vaccine
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- polatuzumab vedotin
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- pomalidomide
- ponatinib
- ponesimod
- pozelimab
- prednisolone
- prednisone
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- ravulizumab
- reslizumab
- revumenib
- rilonacept
- risankizumab
- ritlecitinib
- rituximab
- roflumilast
- romidepsin
- rotavirus vaccine
- rozanolixizumab
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
- rubella virus vaccine
- ruxolitinib
- ruxolitinib topical
- sacituzumab govitecan
- sarilumab
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- satralizumab
- secukinumab
- selinexor
- siltuximab
- siponimod
- sipuleucel-T
- sirolimus
- sirolimus protein-bound
- smallpox and mpox vaccine
- smallpox vaccine
- spesolimab
- staphage lysate (spl)
- sutimlimab
- tacrolimus
- tafasitamab
- talimogene laherparepvec
- talquetamab
- tarlatamab
- tazemetostat
- teclistamab
- temsirolimus
- teriflunomide
- tetanus toxoid
- thalidomide
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- tildrakizumab
- tisagenlecleucel
- tocilizumab
- tofacitinib
- triamcinolone
- typhoid vaccine, inactivated
- typhoid vaccine, live
Allogeneic processed thymus tissue disease interactions
There is 1 disease interaction with allogeneic processed thymus tissue which include:
More about allogeneic processed thymus tissue
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: other immunostimulants
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Copaxone
Copaxone is used to treat relapsing forms of multiple sclerosis (MS) in adults (including ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Mozobil
Mozobil helps patients with non-Hodgkin's lymphoma by releasing stem cells that can be collected ...
Xolremdi
Xolremdi is used to treat WHIM syndrome in adults and children 12 years of age and older to ...
Plerixafor
Plerixafor systemic is used for hematopoietic stem cell mobilization, multiple myeloma ...
Mavorixafor
Mavorixafor is used to treat WHIM syndrome (warts, hypogammaglobulinemia, infections, and ...
Glatiramer
Glatiramer acetate (brand name Copaxone, Glatopa, and generics) is used to treat relapsing forms of ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.